Literature DB >> 17078094

Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration.

Martin Krause1, Wolfgang Fogel, Volker Tronnier, Sabine Pohle, Konstanze Hörtnagel, Ute Thyen, Jens Volkmann.   

Abstract

Pantothenate kinase-associated neurodegeneration (PKAN) is a rare autosomal recessive disorder with onset in childhood and rapid progression. There is no causative and insufficient symptomatic drug therapy. Deep brain stimulation (DBS) of the internal pallidum (GPi) has been reported to improve motor function. Most case reports, however, are limited to short observational periods. The impact of DBS on the progression and life expectancy in PKAN is unknown. We present a 5-year outcome and video documentation of bilateral GPi-DBS of an adolescent patient suffering from genetically defined PKAN. Copyright 2006 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078094     DOI: 10.1002/mds.21166

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  20 in total

Review 1.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 2.  Treatment of dystonia.

Authors:  Mary Ann Thenganatt; Joseph Jankovic
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 3.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

4.  Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation.

Authors:  L Timmermann; K A M Pauls; K Wieland; R Jech; G Kurlemann; N Sharma; S S Gill; C A Haenggeli; S J Hayflick; P Hogarth; K L Leenders; P Limousin; C J Malanga; E Moro; J L Ostrem; F J Revilla; P Santens; A Schnitzler; S Tisch; F Valldeoriola; J Vesper; J Volkmann; D Woitalla; S Peker
Journal:  Brain       Date:  2010-03-05       Impact factor: 13.501

Review 5.  Parkinsonism and inborn errors of metabolism.

Authors:  A Garcia-Cazorla; S T Duarte
Journal:  J Inherit Metab Dis       Date:  2014-06-07       Impact factor: 4.982

6.  Pathophysiology and treatment of neurodegeneration with brain iron accumulation in the pediatric population.

Authors:  Susanne A Schneider; Giovanna Zorzi; Nardo Nardocci
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

7.  Treatment of generalized dystonia.

Authors:  Naomi Lubarr; Susan Bressman
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 8.  Neurodegeneration with Brain Iron Accumulation.

Authors:  Susanne A Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

Review 9.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

Review 10.  Genetic Dystonia-ataxia Syndromes: Clinical Spectrum, Diagnostic Approach, and Treatment Options.

Authors:  Malco Rossi; Bettina Balint; Patricio Millar Vernetti; Kailash P Bhatia; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.